Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Location ESA Headquarters, Paris, France Description ELC Launch Services Capacity Demonstration Manager, Commercial Space Transportation Programme, Strategy and Institutional Launches, Directorate
-
About the Research Programme “Ethics of Socially Disruptive Technologies” (Esdit) is an international research programme of seven academic institutions in the Netherlands. It has a combined budget
-
relations. In addition, you may contribute to scientific methods courses at the bachelor and master's level. Finally, if fitting, you may contribute to Research Master programme in Spatial Sciences and the
-
for the launch system and ground segment in coordination with the relevant programme manager(s), and for the management of the Vega and Space Rider Integrated Programme Team engineering competences. You
-
Location ESA Headquarters, Paris, France Description Ariane 6 LEAP MQO Project Manager, Ariane 6 Programmes, Ariane Programme, Directorate of Space Transportation. Ariane 6 MQO encompasses
-
Education A master’s degree in telecommunications, electrical or computer engineering is required for this post. A PhD in a relevant domain would be considered a plus. Additional requirements General
-
in the Netherlands and abroad from various disciplines (including industrial engineering, human factors, computer science, geography, urban planning, healthcare technology and operations). We conduct
-
engineering or computer sciences is required, with specific skills in: Back-end / Front-end programming languages and frameworks used in the ATD project: ASP.Net, .Net Core, HTML, JavaScript, MS Visual Studio
-
development also brings new challenges, notably in terms of intelligence, interoperability, security and privacy. The mission of the SCS group is to realize the vision of meaningful computing within trusted
-
or products the Van Walree Fund finances and which not. Apply:Is opening 15 March 2026 Guidelines KNAW Van Walree Fund Mentorship programme supporting women 'Thanks in part to the KNAW Van Walree Fund, HypoVax